Sentence examples for apply proprietary from inspiring English sources

The programs use highly granular market data and apply proprietary data science techniques to extract trading profiles of entities behind observed market orders.

Since this platform is well characterized, we could apply proprietary and open source quality control techniques.

In response, Woodcock says, "We cannot apply proprietary data to another application; we can't make it public".

It then applies proprietary machine vision algorithms to the images to identify and count different blood-cell types — with the company claiming its technology simplifies blood testing so that even non-professionals can perform the tests.

Free to download from the Apple AppStore, Hitpad's servers do the heavy lifting in terms of determining what is 'worth knowing' on a day by tracking, measuring and analysing different sources and applying proprietary algorithms.

Probe design was carried out using the Agilent eArray interface [ 70], which applies proprietary prediction algorithms to design 60 mer oligo-probes.

Probe design was carried out using the Agilent eArray interface [ 66], which applies proprietary prediction algorithms to design 60mer oligo-probes.

Qiagen Genomics applied proprietary Masscode technology to measure Masscode tags, which are low-molecular-weight compounds linked to the DNA via a photocleavable linker.

Probe design was carried out using the Agilent eArray interface (https://earray.chem.agilent.com/earray/), which applies proprietary prediction algorithms to design 60-mer oligoprobes.

The GNF Academic Screening Collection consists of a collection of compounds that were selected after applying proprietary algorithms designed to select for optimal compound properties and eliminate undesirable functional groups The screen yielded 4582 hits (0.5% hit rate) that met the cutoff of 50% inhibition.

But the company says it will eventually apply its proprietary platform, Synthetic Biotic™ medicines, to create other biotic medicines for the treatment of major diseases involving inflammation, metabolism, oncology and the central nervous system (CNS) including the company's second program, SYNB1618 (for phenylketonuria/PKU) which is expected to enter the clinic this year.